Influenza Update: Identification and Management of the High-Risk Patient


Release Date: October 30, 2020 
Last Reviewed: October 25, 2020
Expiration Date: October 30, 2021
Time to Complete Activity: 1.0 hour

Faculty Presenter

Michael Angarone, DO
Assistant Professor of Medicine (Infectious Diseases) and Medical Education
Division of Infectious Disease
Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Chicago, IL  

Steering Committee 
Michael Angarone, DO

Assistant Professor of Medicine (Infectious Diseases) and Medical Education
Division of Infectious Disease
Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Chicago, IL
  
Janna L. Williams, MD
Instructor of Medicine 
Division of Infectious Diseases 
Northwestern University Feinberg School of Medicine
Chicago, IL
This activity is provided by Paradigm Medical Communications, LLC.   

Disclosure of Commercial Support
This activity is supported by an educational grant from Genentech, a member for the Roche Group.  
  
Target Audience
This activity been designed to address the educational needs of doctors of osteopathic medicine (DOs) who treat adults and/or children. It may also benefit other healthcare professionals who are interested or involved in the care of patients with, or at risk for, influenza and related complications. 


Statement of Need
DOs who practice in the primary care setting regularly see a wide range of patients (both adults and children) with chronic conditions and other risk factors that make them susceptible to potentially deadly complications of influenza. Yet many high-risk patients go unnoticed and undertreated in primary care, as misperceptions about the role of diagnostic laboratory testing and antiviral therapy abound. The confusion is fueled by the recent availability of the first and only antiviral indicated for both otherwise healthy and high-risk patients that has been ushered into clinical practice along with an abundance of new data and shifting paradigms in influenza care, especially given the current COVID-19 pandemic and related co-infection concerns. In this educational activity, DOs working in primary care and their associated clinical colleagues will explore advances in influenza care, including optimal, evidence-based strategies to identify and treat patients with, or at risk for, influenza who are prone to complications and a longer duration of viral shedding.  
 

Learning Objectives
Upon proper completion of this activity, participants should be better able to:

  • Select appropriate candidates for influenza treatment or prophylaxis based on signs, symptoms, and risk factors
  • Demonstrate appropriate timing of antiviral initiation based on patient characteristics and current evidence, without awaiting laboratory test results 
  • Devise regimens for influenza treatment and prophylaxis that are proven to reduce the duration of illness, viral shedding, and related complications 

Agenda

  • Influenza Is Not Benign, Especially in High-Risk Patients
  • Case Studies: Diagnosing Influenza
  • Antivirals: An Important Tool in the Influenza Treatment Arsenal
  • Case Study: Influenza Treatment in the High-Risk Patient
  • Q&A

Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

PA Continuing Education
PAs may claim a maximum of 1.0 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. 

Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

AOA Credit 
AOA Category 2 CME credit is reciprocal with AMA PRA Category 1 Credit™ and can be claimed by participants in the webinar.

Instructions for Participation 
To receive a CME certificate of participation, you should:

  • Follow instructions to register or log in with your professional information and complete the preactivity assessment

  • View the online activity in its entirety

  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding CME credit, contact the Paradigm CME Department at cme@paradigmmc.com or (845) 398-5949.

Hardware/Software Requirements
This certified CME activity is designed using HTML5 video. As you navigate the video using the supplied controls, the slides will sync to the speaker.

Supported Browsers:
For Desktops (Windows/Mac)
Microsoft Edge 40 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher

For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher

Technical Support: If you have any technical problems or playback issues, email us at contactus@paradigmmc.com.

Disclosures
In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.

Michael Angarone, DO
Consulting fees: AbbVie Inc
Speakers Bureau: Allergan, Inc 

Janna L. Williams, MD 
Consulting fees: AbbVie Inc

Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.

Independent peer, resident/fellow reviewers have no financial relationships to disclose.

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.

Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

As an ACCME-accredited provider, Paradigm Medical Communications, LLC’s activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. 


Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.

Privacy policy
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.

Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com

© 2020 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.